English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

recessive disorder resulting from a defi ciency of acid α-glucosidase (GAA, or acid maltase), includes two main forms – infantileand late-onset glycogen storage disease type II (GSD II). Despite the age of onset and different life prognosis, Pompe disease is a single disease continuum with variable rates of disease progression and different ages of onset. The late-onset form of Pompe disease (LOPD) is a well-known milder form of the GSD II. A 66-years-old man with diffi culties climbing stairs and walking (6MWT less than 10 m), breathing problems, particularly at night when lying down, and abnormal spinal lordosis is described here. The initial signs of the disease were subtle and unrecognized for more than 30 years: inability to whistle since childhood, diffi culties in running long distances, pull-ups and chin-ups, playing running games while being in the army, shortness of breath since age 40 years and periodical general inexplicable fatigue since 45 years; myopathic symptoms, such as force decrease of the hips, pelvic, and trunk muscles, proximal leg muscle atrophy and progressive course of motor disturbances became obvious at age 50 and the patient was classifi ed as having ‘limb–girdle muscular dystrophy of late First Case of Late-Onset Glycogen Storage Disease Type II in Russia with a Novel Mutation